Acupuncture for Headaches & Migraines (2026 Research Update)

If you live with headaches or migraines, you already know how much they can take from your life. The missed work, the cancelled plans, the hours spent in a dark room waiting for the pain to pass. You may have tried various medications and found them helpful, partially helpful, or not helpful at all. You may be concerned about side effects, or about what happens when you need to take medication over months and years.

This blog is different from most you will read online. It is not based on a single study or a personal opinion. It is a synthesis of over 20 peer-reviewed studies published in the last five to seven years, including meta-analyses (studies that combine data from multiple trials to give a stronger overall picture) and randomised controlled trials (the gold standard of clinical research, where patients are randomly assigned to treatment or control groups). Every study cited here has been published in a peer-reviewed medical journal and verified in my research library.

My aim is to give you an honest, evidence-based picture of what acupuncture can do for headaches and migraines, what the research actually shows, and what you can realistically expect if you decide to try it.

Headache disorders are among the most common health problems worldwide.

The two types most people experience are:

A third, much rarer type is cluster headache, an excruciatingly painful headache that occurs in cycles or clusters.

The evidence for acupuncture in tension-type headache has grown substantially in recent years. A 2023 meta-analysis pooling 30 randomised controlled trials with 2,742 participants found that acupuncture was more effective than sham acupuncture (a placebo-like technique where needles are placed at non-acupuncture points or do not penetrate the skin) at improving the responder rate (the proportion of patients who experience at least a 50% reduction in headache frequency) and at reducing headache frequency overall. No serious adverse events associated with acupuncture occurred in any of the 16 trials that evaluated safety. [1]

Another 2023 meta-analysis, this one using trial sequential analysis (a statistical method that checks whether the accumulated evidence is sufficient to draw a firm conclusion), pooled 14 studies with 2,795 participants and confirmed that acupuncture was superior to sham acupuncture in reducing tension-type headache frequency, both immediately after treatment and at follow-up. The authors concluded that acupuncture is an efficacious and safe treatment for tension-type headache prevention, though they noted that the quality of evidence was generally low to very low, meaning further high-quality trials are still needed. [2]

A 2024 indirect comparison meta-analysis asked a particularly practical question: how does acupuncture compare to tricyclic antidepressants (particularly amitriptyline), the first-line drug treatment for tension-type headache prevention? Pooling 34 trials with 4,426 participants, the analysis found that acupuncture had a similar effect to tricyclic antidepressants in reducing headache frequency and intensity, but with a significantly lower rate of adverse events. The odds ratio for adverse events with amitriptyline compared to acupuncture was 4.73, meaning patients on amitriptyline were nearly five times more likely to experience side effects. [3]

A 2025 randomised controlled trial tested auricular acupuncture (acupuncture applied to specific points on the ear) against sham acupuncture in patients with frequent episodic tension-type headache. The auricular acupuncture group showed significant improvements in pain scores, headache index, anxiety, depression scores, and reduced use of acute headache medications, with effects sustained through 24 weeks of follow-up. The incidence of adverse events was similar between the two groups. [4]

Cluster headaches are far rarer than tension-type headache or migraine, and the research base for acupuncture in this condition is much smaller.

A 2023 systematic review identified six randomised controlled trials of acupuncture for cluster headache, all conducted in China, comprising 628 participants. All six trials used manual acupuncture, and two also targeted the sphenopalatine ganglion (a nerve cluster deep in the face associated with cluster headache pain). In every study, adding acupuncture to conventional treatment produced significant improvements in headache attack frequency and pain intensity compared to conventional treatment alone. [5]

One of these trials, published in 2022, randomised 180 patients with episodic cluster headache to conventional acupuncture, sphenopalatine ganglion acupuncture, or a combination of both. The combined approach achieved a total effective rate of 93%, compared to 75.9% for conventional acupuncture alone and 73.7% for sphenopalatine ganglion acupuncture alone, with improvements in pain scores, attack frequency, and quality of life maintained at three-month follow-up. [6]

It should be noted that the randomised controlled trials identified in the 2023 review were all conducted in China, and the evidence base is less robust than for migraine or tension-type headache. Larger, multicentre trials in Western populations are needed to confirm these findings.

The evidence for acupuncture in migraine prevention is now substantial.

A 2025 meta-analysis pooling 19 randomised controlled trials with 2,296 patients found that, compared to conventional medication, acupuncture was associated with greater reductions in migraine attack frequency, pain intensity, number of migraine days, and migraine duration. A higher proportion of acupuncture patients achieved at least a 50% reduction in migraine days, and the overall effective rate was sustained at six-month follow-up, with fewer adverse events reported. The authors noted, however, that the overall quality of evidence was moderate to low, limiting the certainty of these findings. [7]

A landmark 2020 trial published in the BMJ randomised 150 patients with episodic migraine without aura to 20 sessions of manual acupuncture, sham acupuncture, or usual care over eight weeks. Manual acupuncture produced a significantly greater reduction in migraine days than sham acupuncture across weeks 13 to 20 post-treatment, most pronounced at weeks 17 to 20 (a reduction of 3.9 days versus 2.2 days), and a greater reduction in migraine attacks (2.3 versus 1.6). No severe adverse events were reported. The authors concluded that manual acupuncture should be considered in future guidelines for patients reluctant to use prophylactic drugs or when drugs are ineffective. [8]

A 2024 trial published in Cephalalgia compared acupuncture directly against topiramate (a standard migraine preventive medication) in 60 patients with chronic migraine, using a double-dummy design (where one group receives real acupuncture plus a placebo pill, and the other receives sham acupuncture plus real topiramate). Acupuncture produced significantly greater reductions in monthly migraine days than topiramate, with the effect sustained through 24 weeks. No severe adverse events were reported in the acupuncture group. [9]

A 2023 Bayesian network meta-analysis ranked six acupuncture techniques and three types of prophylactic drugs across 40 RCTs with 4,405 participants. Manual acupuncture ranked first for reducing pain scores, migraine attack frequency, and headache days at the 12-week follow-up, ahead of electroacupuncture, calcium antagonists, beta-blockers, and other drug classes. [10]

A 2026 randomised controlled trial tested acupuncture for acute migraine treatment (relieving an attack that is already happening, rather than preventing future attacks). In 80 patients with active migraine without aura, real acupuncture produced an analgesic response rate of 92.5% within 10 minutes, compared to 12.5% in the sham group. Pain intensity scores dropped significantly from the first minute, peaking at 10 minutes, and nausea was also significantly reduced. No adverse events were observed. [11]

Menstrual migraine, linked to the natural drop in oestrogen before menstruation, is notoriously difficult to treat with standard medication. The research in this specific area is particularly strong.

A 2022 multicentre randomised controlled trial in China randomised 172 women with menstruation-related migraine to either 24 sessions of acupuncture plus placebo medication, or sham acupuncture plus naproxen (an NSAID). The acupuncture group showed an average reduction of 0.94 migraine days per perimenstrual period (the days around menstruation), compared to 0.61 days in the medication group, with the preventive effect sustained for six menstrual cycles after treatment ended. [12]

A 2025 updated meta-analysis of 39 randomised controlled trials with 2,584 participants found that acupuncture significantly reduced pain intensity, migraine attack frequency, and duration in menstrual migraine, improved response rates, and was associated with increased serum 5-hydroxytryptamine (5-HT, or serotonin) levels, a neurotransmitter involved in migraine regulation. The authors noted a favourable safety profile, though the overall certainty of evidence was low due to heterogeneity across studies. [13]

Understanding how acupuncture works does not require you to abandon either a Western medical framework or an appreciation of traditional Chinese medicine. The research points to several overlapping mechanisms, each of which contributes to pain relief in headaches and migraines.

One of the most common questions I am asked is whether acupuncture works as well as medication. The recent evidence is encouraging.

For migraine prevention, the 2025 meta-analysis of 19 RCTs found acupuncture superior to conventional oral medication across multiple outcomes, including attack frequency, intensity, migraine days, and duration, with fewer adverse events and a higher sustained response rate at six months. [7]

The 2024 Cephalalgia trial directly compared acupuncture to topiramate (a leading migraine preventive drug) and found acupuncture superior, with effects sustained for 24 weeks. [9]

For tension-type headache, the 2024 indirect comparison found acupuncture had a similar effect to tricyclic antidepressants for reducing headache frequency and intensity, but with nearly five times fewer adverse events. [3]

A 2025 meta-analysis comparing acupuncture to standard medical care for migraine prophylaxis found that while acupuncture did not show a statistically significant difference in reducing migraine days or pain intensity compared to standard care, it did reduce analgesic use and improve quality of life, supporting its role as an adjunctive (add-on) therapy. [19]

It is worth noting that sham acupuncture (the placebo control used in trials) itself has a strong effect on migraine prevention. A 2024 network meta-analysis of 50 trials with 4,880 subjects found that sham acupuncture had the greatest placebo effect among all non-pharmacologic placebo controls tested, including sham transcranial magnetic stimulation and sham vagus nerve stimulation. [20] This means that some of the benefit patients experience in the sham arm may come from the ritual and expectation of treatment, and from the fact that sham acupuncture is not a completely inert control. Nevertheless, in head-to-head trials real acupuncture consistently outperforms placebo acupuncture, confirming a specific therapeutic effect beyond these factors. [1,2,8]

Clinical bottom line: Acupuncture performs at least as well as, and in some studies better than, standard preventive medications for both migraine and tension-type headache, with substantially fewer side effects.

The safety data for acupuncture is reassuring. The most comprehensive systematic review of acupuncture safety, published in BMJ Open in 2021, pooled data from 21 prospective studies covering over 12.9 million treatments. The findings were clear:

The authors concluded that “acupuncture can be considered among the safer treatments in medicine.” [21]

In the headache-specific trials cited in this blog, no serious adverse events were reported in the acupuncture groups of the BMJ migraine trial, the Cephalalgia chronic migraine trial, the acute migraine treatment trial, or the auricular acupuncture tension-type headache trial. [4,8,9,11]

However, safety depends on the practitioner. The Bäumler review noted that serious adverse events are “claimed to be avoidable by proper acupuncture training and practice,” and that cases of malpractice were uncommon in the included studies precisely because most acupuncturists were well trained. [21] This is why choosing a properly qualified practitioner matters (see below).

Clinical bottom line: Acupuncture is one of the safer treatments in medicine. Serious adverse events are extremely rare, and most minor side effects are mild and transient. Safety depends on the training and competence of the practitioner.

In research trials, the most commonly used acupuncture points for headaches include:

However, this list is only a starting point. In clinical practice, point selection is individualised based on each patient’s specific presentation, including the location and quality of the pain, accompanying symptoms, the patient’s overall health, and the underlying pattern from a traditional Chinese medicine perspective. Two patients with the same diagnosis of migraine may receive entirely different point prescriptions.

The success of treatment often depends on the skill of the practitioner in selecting and adapting the right points for each individual.

Yes. The National Institute for Health and Care Excellence (NICE), the body that advises the NHS on which treatments to provide, recommends acupuncture for two headache conditions in its guideline CG150 (Headaches in over 12s: diagnosis and management, last reviewed December 2025):

Acupuncture also has over 9,000 positive recommendations from official government and clinical guidelines worldwide, across dozens of conditions. [23]

The number of sessions recommended varies between studies and guidelines, and there is an important difference between Chinese and Western research that patients should understand.

Chinese studies typically use intensive protocols: 20 to 30 sessions over several weeks, sometimes daily. For example, the BMJ migraine trial used 20 sessions over 8 weeks, and the menstrual migraine trial used 24 sessions over three menstrual cycles. [8,12]

Western studies tend to use fewer sessions. A Thai multicentre trial published in 2022 compared 5 sessions versus 10 sessions of acupuncture for migraine across five hospitals. Both groups showed apparent reductions in headache days (a mean reduction of 6.4 days in both groups) and pain severity, with improvements in quality of life. The effects were not significantly different between the two groups, suggesting that even a shorter course may provide meaningful benefit. However, the study was designed as a non-inferiority trial and was unable to definitively prove that 5 sessions were as good as 10. [24]

NICE recommends a course of up to 10 sessions over 5 to 8 weeks for both chronic tension-type headache and migraine prophylaxis. [22]

In my clinical practice, I typically recommend an initial course of 6 to 10 weekly sessions, with regular reviews to monitor response. Some patients respond quickly and need fewer sessions, while others with chronic or long-standing headache patterns may benefit from ongoing maintenance treatments at monthly or longer intervals.

The follow-up data from recent trials is encouraging:

In practice, the duration of benefit varies between individuals. Some patients experience lasting relief after a single course, while others find that periodic maintenance treatments help sustain the effect.

When you come to see me, your first appointment will last approximately 70 to 80 minutes. Here is what happens:

Full medical history. I take a comprehensive history, not just of your headaches but of your overall health. This includes when your headaches started, what type they are, how often they occur, how severe they are, what triggers them, what medications you have tried, and what tests (if any) have been done. I also review lifestyle factors that may be contributing, such as sleep, stress, hydration, caffeine intake, screen time, and hormonal patterns.

Physical and traditional Chinese medicine assessment. I examine your pulse and tongue (traditional diagnostic methods in Chinese medicine), if relevant, palpate (feel) areas of tension in your neck, shoulders, and scalp, and assess your range of motion. This helps me identify the underlying pattern from a TCM perspective, which guides point selection.

Informed consent and treatment plan. Before any needling, I discuss the potential benefits and risks of treatment, answer your questions, and ensure you are comfortable proceeding. I will also discuss a proposed treatment plan, including how many sessions I recommend, how frequently, and what outcomes to expect. I may also suggest any lifestyle adjustments that may help. This is a standard part of professional practice.

First treatment. Your first session usually includes your first acupuncture treatment. I will explain each step as I go. The needles are very fine (much thinner than injection needles), and most people feel little or no discomfort on insertion. You will rest with the needles in place for 15 to 20 minutes. Many patients find this deeply relaxing, and some fall asleep.

Yes, enormously. This is one of the most important things to understand if you are considering acupuncture.

Acupuncture qualification in the UK ranges from practitioners who have completed a few hours of online training with no exams and no supervised clinical practice, to those who have completed a full degree or master’s level qualification with hundreds of hours of supervised clinical training.

I trained for four years at the Northern College of Acupuncture in York, qualifying with an MSc in Acupuncture. This included extensive supervised clinical practice, training in Western medical sciences (anatomy, physiology, pathology, pharmacology), and rigorous examination. I have over 20 years of clinical experience and am a member of the British Acupuncture Council, the leading professional body for acupuncturists in the UK. I am also a Member of the British Medical Acupuncture Society (BMAS) and a Member of the Association of Acupuncture Clinicians (AAC).

The safety data supports the importance of proper training. As the Bäumler review noted, serious adverse events are “claimed to be avoidable by proper acupuncture training and practice,” and the low rate of serious events in the research literature reflects the fact that most acupuncturists in the studies were well trained. [21]

When choosing an acupuncturist, I recommend looking for someone who has completed a minimum of three years of full-time acupuncture training (or equivalent), and has experience treating headache conditions specifically.

The evidence for acupuncture in headaches and migraines is stronger now than it has ever been:

If you are living with headaches or migraines and are looking for an evidence-based, safe, and medication-free option, acupuncture is well worth considering. The key is finding a properly qualified practitioner who can tailor the treatment to your individual needs.

[1]

W. Kang, X. Xiao, R. Fan, D. Zhong, Y. Li, J. She, J. Li, Y. Feng, R. Jin, Acupuncture for tension-type headache: A systematic review and meta-analysis of randomized controlled trials, Frontiers in Neurology 13 (2023). https://doi.org/10.3389/fneur.2022.943495.

[2]

Q.-F. Tao, X.-Y. Wang, S.-J. Feng, X.-Y. Xiao, Y.-Z. Shi, C.-R. Xie, H. Zheng, Efficacy of acupuncture for tension-type headache prophylaxis: Systematic review and meta-analysis with trial sequential analysis, Journal of Neurology 270 (2023) 3402–3412. https://doi.org/10.1007/s00415-023-11695-1.

[3]

Q.-F. Tao, Y.-B. Huang, L. Yuan, Y.-Z. Shi, D. Qin, K. Ye, W.-Y. Peng, C.-R. Xie, H. Zheng, Acupuncture versus tricyclic antidepressants in the prophylactic treatment of tension-type headaches: An indirect treatment comparison meta-analysis, The Journal of Headache and Pain 25 (2024). https://doi.org/10.1186/s10194-024-01776-5.

[4]

X. Jin, Z. Xu, T. Gao, G. Wang, W. Dong, J. Jin, Y. Yan, The clinical efficacy of auricular acupuncture in the treatment of frequent episodic tension-type headache: A single-blind randomized controlled trial, BMC Complementary Medicine and Therapies 25 (2025). https://doi.org/10.1186/s12906-025-05063-x.

[5]

S. Kim, A. Lee, I. Lee, Recent Clinical Research on Acupuncture Therapy for Cluster Headache, The Journal of Internal Korean Medicine 44 (2023) 1197–1211. https://doi.org/10.22246/jikm.2023.44.6.1197.

[6]

F. Zai, L. Ji, J.-H. Cheng, Y.-R. Chen, H. Liu, Acupuncture at sphenopalatine ganglion combined with conventional acupuncture for episodic cluster headache: A randomized controlled trial, Zhongguo Zhen Jiu 42 (2022) 603–607. https://doi.org/10.13703/j.0255-2930.20211111-k0007.

[7]

A.R. Liu, Q. Zhu, J. Li, Y. Cao, T. Pei, L. Shi, Efficacy of Acupuncture and Pharmacotherapy for Migraine Prophylaxis: A Systematic Review and Meta-Analysis, Journal of Pain Research Volume 18 (2025) 2521–2540. https://doi.org/10.2147/JPR.S519846.

[8]

S. Xu, L. Yu, X. Luo, M. Wang, G. Chen, Q. Zhang, W. Liu, Z. Zhou, J. Song, H. Jing, G. Huang, F. Liang, H. Wang, W. Wang, Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: Multicentre, randomised clinical trial, BMJ (2020) m697. https://doi.org/10.1136/bmj.m697.

[9]

L. Liu, Q. Chen, L. Zhao, T. Lyu, L. Nie, Q. Miao, Y. Liu, L. Zheng, F. Fu, Y. Luo, C. Zeng, C. Zhang, P. Peng, Y. Zhang, B. Li, Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial, Cephalalgia 44 (2024). https://doi.org/10.1177/03331024241261080.

[10]

Z. Song, Y. Liu, S. Cui, J. Hu, W. Ma, Z. Chen, J. Huo, Q. Gao, S. Ma, J. Wang, Effectiveness of Acupuncture for Prophylactic Treatment of Migraine: A Systematic Review and Bayesian Network Meta‐Analysis, Advanced Biology 7 (2023). https://doi.org/10.1002/adbi.202300134.

[11]

Y. Deng, S. Zhang, F. Yao, S. Zhao, G. Huang, R. Yang, H. Wang, X. Tang, Y. Huang, Q. Li, X. Pei, Z. Liu, F. Liang, T. Guo, Acupuncture for acute treatment of migraine without aura: A randomized clinical trial, Headache: The Journal of Head and Face Pain (2026). https://doi.org/10.1111/head.70144.

[12]

L. Liu, C.-S. Zhang, H.-L. Liu, F. He, T.-L. Lyu, L. Zeng, L.-P. Zhao, M.-N. Wang, Z.-Y. Qu, L.-M. Nie, J. Guo, X.-Z. Zhang, Y.-H. Lu, K.-L. Wang, B. Li, X.-H. Jing, L.-P. Wang, Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial, Frontiers in Neuroscience 16 (2022). https://doi.org/10.3389/fnins.2022.992577.

[13]

Q. Wu, L. Fan, D. Wu, H. Gao, D. Han, H. Hu, L. Qian, Determining the efficacy and safety of acupuncture for the treatment of menstrual migraine: An updated systematic review and meta-analysis, Frontiers in Neurology 16 (2025). https://doi.org/10.3389/fneur.2025.1673321.

[14]

M.T. Cabýoglu, N. Ergene, U. Tan, THE MECHANISM OF ACUPUNCTURE AND CLINICAL APPLICATIONS, International Journal of Neuroscience 116 (2006) 115–125. https://doi.org/10.1080/00207450500341472.

[15]

M. Li, H. Huang, L. Yao, H. Yang, S. Ma, H. Zheng, Z. Zhong, S. Yu, B. Yu, H. Wang, Effect of acupuncture on the modulation of functional brain regions in migraine: A meta-analysis of fMRI studies, Frontiers in Neurology 14 (2023). https://doi.org/10.3389/fneur.2023.1036413.

[16]

Y.-W. Li, W. Li, Y.-N. Gong, B.-M. Dou, Z.-X. Lyu, L. Ulloa, S.-J. Wang, Z.-F. Xu, Y. Guo, The autonomic nervous system: A potential link to the efficacy of acupuncture, Front. Neurosci. 16 (2022). https://doi.org/10.3389/fnins.2022.1038945.

[17]

Z. Gao, X. Yan, R. Wang-Sattler, M. Covic, G. Yu, F. Ge, J. Lin, Q. Chen, J. Liu, S. Sharma, S. Molnos, B. Kuehnel, R. Wilson, J. Adam, S. Brandmaier, S. Yu, F. Liang, C. Gieger, Metabolomics Reveals Reasons for the Efficacy of Acupuncture in Migraine Patients: The Role of Anaerobic Glycolysis and Mitochondrial Citrate in Migraine Relief, Phenomics 5 (2025) 707–728. https://doi.org/10.1007/s43657-024-00205-6.

[18]

M. Qi, Y. Wang, Y. Zhang, Y. Feng, B. Liu, Potential neural mechanisms of acupuncture therapy on migraine: A systematic review and activation likelihood estimation meta-analysis update, Quant Imaging Med Surg 15 (2025) 1653–1668. https://doi.org/10.21037/qims-24-916.

[19]

F. Pistoia, S. Cesarano, G. Saporito, M. Albanese, C. Lucenti, S. Scarsella, A. Liguori, F.U. Ronchi, Acupuncture Versus Standard Medical Care in the Prophylactic Treatment of Migraine: A Systematic Review and Meta‐Analysis, Eur J Neurol 32 (2025) e70160. https://doi.org/10.1111/ene.70160.

[20]

Y.-B. Huang, L. Yuan, X.-Y. Xiao, X.-Y. Wang, S.-J. Feng, H. Zheng, Effect of different non-pharmacologic placebo treatments on migraine prevention: A network meta-analysis of randomized controlled trials, Acta Neurologica Belgica 124 (2024) 1125–1139. https://doi.org/10.1007/s13760-023-02460-2.

[21]

P. Bäumler, W. Zhang, T. Stübinger, D. Irnich, Acupuncture-related adverse events: Systematic review and meta-analyses of prospective clinical studies, BMJ Open 11 (2021) e045961. https://doi.org/10.1136/bmjopen-2020-045961.

[22]

NICE, Headaches in over 12s: Diagnosis and management | Guidance CG150 | NICE, (2025). https://www.nice.org.uk/guidance/cg150/ifp/chapter/About-this-information (accessed August 9, 2026).

[23]

M.H. Koppelman, Acupuncture: Effective and Recommended but More Implementation Needed, Chinese Medicine and Culture 7 (2024) 86–93. https://doi.org/10.1097/MC9.0000000000000093.

[24]

T. Supasiri, C. Jariengprasert, M. Phithaksilp, P. Sangtongpanichakul, S. Anotayanonth, T. Buranatawonsom, K. Pongpirul, A randomized controlled clinical trial comparing different numbers of acupuncture sessions for migraine, Acupunct Med 40 (2022) 215–223. https://doi.org/10.1177/09645284211056017.

[25]

H.-Y. Wu, C.-S. Wang, Y.-C. Liu, C.-C. Chung, W.-L. Chen, C.-I. Tsai, C.-Y. Hsu, C.-H. Chou, Enhancing chronic migraine preventive therapy: Low-level 810 nm laser acupuncture as an add-on treatment for patients with unsatisfactory pharmacological effect, a pilot single-blind randomized controlled trial, BMC Complementary Medicine and Therapies 24 (2024). https://doi.org/10.1186/s12906-024-04617-9.